Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Trientine hydrochloride by Innolife for Systolic Heart Failure: Likelihood of Approval
Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Systolic Heart Failure. According to GlobalData,...
Trientine hydrochloride by Innolife for Amyloidosis: Likelihood of Approval
Trientine hydrochloride is under clinical development by Innolife and currently in Phase I for Amyloidosis. According to GlobalData, Phase I...
Trientine hydrochloride by Innolife for Coronary Artery Disease (CAD) (Ischemic Heart Disease): Likelihood of Approval
Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart...